Clarient, Inc. (Clarient) is an oncology diagnostics services company. The Company delivers oncology diagnostic testing services to community pathologists, biopharmaceutical companies, and researchers. As of December 31, 2008, all of the Company's services were provided within the United States, and substantially all of the Company's assets were located within the United States. The Company provides a range of cancer diagnostic and consultative services, which includes technical laboratory services and professional interpretation; such reports and analyses are provided through its Internet-based application, PATHSiTE. Clarient’s technologies used to assess and characterize cancer include immunohistochemistry (IHC), flow cytometry, molecular/PCR, fluorescent in situ hybridization (FISH), cytogenetics, and histology.